CM
KIN

Caption Management’s Kindred Biosciences, Inc. KIN Stock Holding History

Caption Management’s Portfolio KIN Stock Details KIN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-27,000
Closed -$185K – 1066
2019
Q3 		$185K Hold
27,000
– – 0.01% 595
2019
Q2 		$225K Buy
+27,000
New +$233K 0.01% 556

Other funds holding KIN

PWAM
Park West Asset Management San Francisco, California $1.18B AUM 47.25% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return

Caption Management's KIN Position: Q4 2019 in Review

Caption Management sold out of Kindred Biosciences, Inc. (KIN) in Q4 2019, closing a stake of 27,000 shares — an estimated $185K sold.

Caption Management first reported a position in KIN in Q2 2019 and held it in 2 quarters. The position peaked at $225K in Q2 2019. 75 funds tracked by Wall St. Rank hold KIN as of Q4 2019.

  • Caption Management reported no remaining Kindred Biosciences, Inc. position as of Q4 2019 after selling out during the quarter.
  • Caption Management sold 27,000 Kindred Biosciences, Inc. shares in Q4 2019, an estimated $185K.
  • Caption Management first reported a position in Kindred Biosciences, Inc. in Q2 2019 and held it in 2 quarters.
  • Caption Management's Kindred Biosciences, Inc. position peaked at $225K in Q2 2019.
  • 75 funds tracked by Wall St. Rank held Kindred Biosciences, Inc. as of Q4 2019.

Based on Caption Management's 13F filing for Q4 2019, filed 13 Feb 2020.